ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
25.32
+1.60 (6.75%)
At close: Jun 26, 2026, 4:00 PM EDT
25.50
+0.18 (0.71%)
Pre-market: Jun 29, 2026, 7:22 AM EDT
ACADIA Pharmaceuticals Employees
As of December 31, 2025, ACADIA Pharmaceuticals had 798 total employees, including 796 full-time and 2 part-time employees. The number of employees increased by 144 or 22.02% compared to the previous year.
Employees
798
Change (1Y)
144
Growth (1Y)
22.02%
Revenue / Employee
$1,372,494
Profits / Employee
$470,739
Market Cap
4.34B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Arcus Biosciences | 601 |
| Crinetics Pharmaceuticals | 594 |
| Denali Therapeutics | 507 |
| Relay Therapeutics | 193 |
| Catalyst Pharmaceuticals | 182 |
| Celcuity | 155 |
| Edgewise Therapeutics | 154 |
| Tango Therapeutics | 137 |
ACAD News
- 38 minutes ago - Acadia Pharmaceuticals price target raised to $36 from $32 at Canaccord - TheFly
- 11 hours ago - Citi adds ‘upside 90-day catalyst watch’ on Acadia Pharmaceuticals - TheFly
- 11 hours ago - Acadia Pharmaceuticals price target raised to $35 from $32 at Citi - TheFly
- 2 days ago - Acadia Pharmaceuticals rises 13.4% - TheFly
- 2 days ago - Acadia Pharmaceuticals Stock (ACAD) Jumps on a Positive CHMP Review - TipRanks
- 2 days ago - Acadia Pharmaceuticals rises 9.9% - TheFly
- 3 days ago - Acadia Pharmaceuticals: Daybu recommended for approval in EU by CHMP - TheFly
- 3 days ago - DAYBU® (trofinetide) Recommended for Approval in the European Union by CHMP - Business Wire